Clinical Trial Update: Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia [Phase 3]

View source ↗

Summary

Phase 3 trial update for a tetravalent dengue vaccine in healthy children showed completed status with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever
• Dengue Hemorrhagic Fever

Drugs mentioned

• Tetravalent dengue vaccine

Snippet

Sponsor: Sanofi | Conditions: Dengue Fever, Dengue Hemorrhagic Fever | Phase 3 | Status: COMPLETED | Results posted: 2019-07-29